Hosted on MSN13m
These 2 Red-Hot Tech Stocks Are ‘Immune’ From Trump’s Tariffs. Should You Buy Them Now?True to his word, President Donald Trump fired the first salvo and imposed tariffs on the largest trading partners of the U.S ...
Investor's Business Daily on MSN37m
Eli Lilly Earnings Top, 2025 Guidance Strong, But Weight-Loss Drug Sales MissEli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
Artificial intelligence (AI) investing experienced a shakeup at the end of January with the release of DeepSeek's R1 model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback